As of January 4th, we have signed an annual CRO agreement with Sun Bio Inc. for non-clinical 疗效 testing and 毒性 testing services for drugs under development.
Through this agreement, we will maintain research collaboration from the 临床前 phase through to 临床试验 for PEG drugs being developed by Sun Bio, and use this as an opportunity to deepen cooperation in drug and product development based on mutual trust and good faith.
This collaboration was established on the basis of trust in RudaCure's 疗效 testing and 毒性 systems. RudaCure is currently conducting 疗效 verification, pharmacokinetic studies, and 毒性 testing for drugs from Sun Bio, 首尔大学 J-MAX, dental product developer ODS, Daewoong 制药, and Vivozon.